April 24, 2019 | Michael Easterling and Samantha Bonar
City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient, a remarkable milestone considering that the initiative started with just two physicians, three beds and guarded expectations in 1976.
CAR T researcher Saul Priceman wants to teach your body to fight cancer
September 13, 2018 | Letisia Marquez
Since 2013, City of Hope researcher Saul Priceman, Ph.D., and his team have developed one of most comprehensive CAR T programs in the nation.
CAR T Laboratory Research Yields Promising Prostate Cancer Results
April 17, 2018 | Letisia Marquez
City of Hope physicians have successfully treated blood cancers with chimeric antigen receptor (CAR) T cell therapy, and they are working to expand that therapy to patients with prostate cancer and other solid tumors.
With New CAR T Approach, City of Hope CEACAM Research Comes Full Circle
February 9, 2018 | Jyoti Madhusoodanan
CEA remains one of the most widely used clinical markers of cancer. As the diverse roles of CEA and CEACAMs, have grown clearer, researchers at City of Hope are working on a new wave of clinical tools and therapies.
New Target for Prostate Cancer Treatment and Prevention Identified
March 29, 2017 | Katie Neith
While prostate cancer is often treated successfully, it is still the third leading cancer killer among men and represents a huge health and economic burden. Now, a team from City of Hope believes they have found a key mechanism for potentially keeping the disease at bay, both before and after diagnosis.
Beating prostate cancer: ‘We’re taking off the brakes’
March 24, 2016 | City of Hope
Researchers at City of Hope believe they are on the verge of significant headway in the treatment of advanced prostate cancer, thanks to new thinking and “staggering” early success.